AdaptHealth (NASDAQ:AHCO – Get Free Report) had its price objective hoisted by equities research analysts at Truist Financial from $12.00 to $14.00 in a report released on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the stock. Truist Financial’s price objective would suggest a potential upside of 31.58% from the stock’s previous close.
Other equities research analysts also recently issued reports about the company. Royal Bank of Canada decreased their price objective on AdaptHealth from $13.00 to $11.00 and set an “outperform” rating on the stock in a report on Tuesday, November 19th. Canaccord Genuity Group decreased their price target on AdaptHealth from $14.00 to $13.00 and set a “buy” rating on the stock in a research note on Wednesday, November 6th. UBS Group lowered their price target on AdaptHealth from $12.00 to $11.00 and set a “buy” rating on the stock in a research report on Thursday, February 13th. Finally, Robert W. Baird reduced their target price on shares of AdaptHealth from $16.00 to $14.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 6th. Five research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average price target of $12.60.
Read Our Latest Analysis on AHCO
AdaptHealth Trading Up 24.4 %
Institutional Investors Weigh In On AdaptHealth
Several institutional investors have recently added to or reduced their stakes in the stock. Intech Investment Management LLC raised its holdings in shares of AdaptHealth by 223.2% in the third quarter. Intech Investment Management LLC now owns 59,650 shares of the company’s stock valued at $670,000 after purchasing an additional 41,196 shares during the last quarter. Victory Capital Management Inc. increased its stake in AdaptHealth by 727.4% in the 3rd quarter. Victory Capital Management Inc. now owns 141,507 shares of the company’s stock valued at $1,589,000 after buying an additional 124,404 shares during the last quarter. Royce & Associates LP lifted its position in AdaptHealth by 13.5% during the 3rd quarter. Royce & Associates LP now owns 777,405 shares of the company’s stock worth $8,730,000 after buying an additional 92,740 shares in the last quarter. Barclays PLC boosted its stake in shares of AdaptHealth by 361.3% during the 3rd quarter. Barclays PLC now owns 181,240 shares of the company’s stock worth $2,034,000 after buying an additional 141,949 shares during the last quarter. Finally, Principal Financial Group Inc. grew its holdings in shares of AdaptHealth by 39.7% in the 3rd quarter. Principal Financial Group Inc. now owns 543,744 shares of the company’s stock valued at $6,106,000 after acquiring an additional 154,434 shares in the last quarter. 82.67% of the stock is owned by institutional investors.
About AdaptHealth
AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.
Featured Stories
- Five stocks we like better than AdaptHealth
- What is the Hang Seng index?
- Wall Street’s Most Wanted: 2 Highly Shorted Stocks Right Now
- What is an Earnings Surprise?
- Etsy Loses Its Meme Stock Shine – Is It Still a Buy?
- What Are the FAANG Stocks and Are They Good Investments?
- Stanley Druckenmiller Bets Big on Airline Stocks – Should You?
Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter.